Gulba DC - Search Results

1

Thrombolysis in thromboembolic diseases.

Gulba DC, Dechend R. Gulba DC, et al. Ann Hematol. 1994 Oct;69(4):S41-57. doi: 10.1007/BF02215958. Ann Hematol. 1994. PMID: 7948299 Review.

2

Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.

Gulba DC, Tanswell P, Dechend R, Sosada M, Weis A, Waigand J, Uhlich F, Hauck S, Jost S, Rafflenbeul W, Lichtlen PR, Dietz R. Gulba DC, et al. J Am Coll Cardiol. 1997 Dec;30(7):1611-7. doi: 10.1016/s0735-1097(97)00370-7. J Am Coll Cardiol. 1997. PMID: 9385884 Free article. Clinical Trial.

3

Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC. Müller DN, et al. Am J Pathol. 2000 Jul;157(1):111-22. doi: 10.1016/S0002-9440(10)64523-3. Am J Pathol. 2000. PMID: 10880382 Free PMC article.

4

Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor.

Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, Bieringer M, Gulba D, Dietz R, Luft FC, Haller H. Dechend R, et al. Circulation. 2001 Jul 31;104(5):576-81. doi: 10.1161/hc3001.092039. Circulation. 2001. PMID: 11479256

5

Stent implantation in patients with superior vena cava syndrome.

Gross CM, Krämer J, Waigand J, Uhlich F, Schröder G, Thalhammer C, Dechend R, Gulba DC, Dietz R. Gross CM, et al. Among authors: gulba dc. AJR Am J Roentgenol. 1997 Aug;169(2):429-32. doi: 10.2214/ajr.169.2.9242747. AJR Am J Roentgenol. 1997. PMID: 9242747

6

AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor.

Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC. Dechend R, et al. Among authors: gulba dc. Circulation. 2000 May 23;101(20):2382-7. doi: 10.1161/01.cir.101.20.2382. Circulation. 2000. PMID: 10821814

7

[Thrombolytic therapy of renal artery embolism. An expanded case report with review of the literature].

Gulba DC, Gross M, Dechend R, Luft F, Sosada M, Frey U, Dietz R. Gulba DC, et al. Internist (Berl). 1996 Jun;37(6):623-7. Internist (Berl). 1996. PMID: 8767996 Review. German. No abstract available.

8

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.

Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, Gulba DC. Dechend R, et al. Among authors: gulba dc. Circulation. 1999 Sep 28;100(13):1369-73. doi: 10.1161/01.cir.100.13.1369. Circulation. 1999. PMID: 10500035

9

Thrombolytic agents--an overview.

Gulba DC, Bode C, Runge MS, Huber K. Gulba DC, et al. Ann Hematol. 1996;73 Suppl 1:S9-27. Ann Hematol. 1996. PMID: 8853112 Review.

10

[Undesirable side effects in thrombolytic therapy].

Claus G, Gulba DC. Claus G, et al. Among authors: gulba dc. Z Gesamte Inn Med. 1993 Jun-Jul;48(6-7):296-303. Z Gesamte Inn Med. 1993. PMID: 8333226 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters